CARB-X funds Procarta Biosystems to develop oligonucleotide-based antibiotics to combat life-threatening Gram-negative pathogens - BioSpace

CARB-X funds Procarta Biosystems to develop oligonucleotide-based antibiotics to combat life-threatening Gram-negative pathogens  BioSpace

Published: Sep 17, 2019. Procarta's new class of antibiotics targets ESKAPE superbugs. (BOSTON, MA) – CARB-X is awarding Procarta Biosystems, ...



Comments

Popular posts from this blog

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today